Cart
sales@molnova.com
Monoamine Transporter
The monoamine neurotransmitter transporters (MATs) are part of the solute carrier 6 (SLC6) family of transporters. They are expressed in the central nervous system (CNS) among other places, where they play a critical al role in regulating monoamine neurotransmitter homeostasis. There are three types of MATs, namely dopamine transporter (DAT, SLC6A3), norepinephrine transporter (NET, SLC6A2), and serotonin transporter (SERT, SLC6A4) which mediate the uptake of monoamine neurotransmitters dopamine (DA), norepinephrine (NE), and serotonin (5-HT), respectively, from the extracellular space into the intracellular compartment. All three transporters are membrane-embedded proteins and in the CNS exclusively expressed in the presynaptic neuronal terminals of their respective pathways.
The MATs play a pivotal role in controlling the signal amplitude and duration of monoaminergic neurotransmission by altering the concentration of monoamines in the extracellular space of the CNS. MATs also undergo regulation directly or indirectly by a number of kinases e.g., protein kinase C (PKC), cAMP-dependent protein kinase (protein kinase A, PKA), cGMP-dependent protein kinase (protein kinase G), Ca2+/calmodulin-dependent protein kinase II, ERK1/2, p38 mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt and tyrosine kinases. Careful design and interpretation of biochemical and behavioral assays to evaluate the function and pharmacology of MAT ligands is necessary to delineate them as competitive inhibitors, allosteric modulators, substrates or releasers.
References
1.Aggarwal S, Mortensen OV. Curr Protoc Pharmacol. 2017;79:12.16.1–12.16.17.
The MATs play a pivotal role in controlling the signal amplitude and duration of monoaminergic neurotransmission by altering the concentration of monoamines in the extracellular space of the CNS. MATs also undergo regulation directly or indirectly by a number of kinases e.g., protein kinase C (PKC), cAMP-dependent protein kinase (protein kinase A, PKA), cGMP-dependent protein kinase (protein kinase G), Ca2+/calmodulin-dependent protein kinase II, ERK1/2, p38 mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt and tyrosine kinases. Careful design and interpretation of biochemical and behavioral assays to evaluate the function and pharmacology of MAT ligands is necessary to delineate them as competitive inhibitors, allosteric modulators, substrates or releasers.
References
1.Aggarwal S, Mortensen OV. Curr Protoc Pharmacol. 2017;79:12.16.1–12.16.17.
Membrane Transporter/Ion Channel
AMPK(58)
ASBT Transporter(6)
BCRP(10)
Beta Amyloid(69)
Carbonic Anhydrase(40)
Chloride Channel(34)
CRAC Channel(0)
CRM1(5)
Exportin-1(5)
FABP(6)
GAT(63)
GLUT(5)
Glutamate Transporter(1)
GlyT(13)
HCN Channel(5)
iGluR(52)
Monoamine Transporter(26)
Monocarboxylate Transporter(12)
MTP(1)
nAChR(5)
NADPH(35)
Na-K-ATPase(2)
NKCC(4)
NMDAR(65)
OCT(4)
Other Targets(13)
P2X Receptor(23)
P-glycoprotein(14)
Proton Pump(38)
Sodium Channel(147)
TRP/TRPV Channel(115)
URAT1(1)
Monoamine Transporter
-
Coumarin102
catalog no : M36953
cas no: 41267-76-9
Coumarin102 (Exciton 480) is a fluorescent dye.Coumarin102 has weak inhibitory activity against Monoamine oxidase B, MAO-B and MAO-A and can be used to study neurological disorders.
-
Simtuzumab
catalog no : M36673
cas no: 1318075-13-6
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2).
-
Lenumlostat
catalog no : M36314
cas no: 2098884-52-5
Lenumlostat is an orally available, selective and potent lysyl oxidase-like protein 2 (LOXL2) inhibitor with inhibitory effects on hLOXL2, hLOXL3 and LOXL2 for the study of fibrotic diseases.
-
FFN 206 dihydrochloride
catalog no : M35261
cas no: 1883548-88-6
FFN 206 dihydrochloride is a fluorescent VMAT2 substrate that can be used to detect VMAT2 subcellular sites in cell culture and shows no detectable inhibition of DAT.
-
CCT365623
catalog no : M34200
cas no: 2126134-01-6
CCT365623 is an orally bioavailable Lysyl Oxidase inhibitor with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy.